Article Details
Retrieved on: 2018-01-03 18:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>VC firm <b>New Enterprise Associates</b> led a $3m round in 2014 with contributions from Pfizer Venture Investments and Amgen Business Development, respective corporate venturing units of biopharmaceutical firms Pfizer and Amgen. NexImmune had previously disclosed $287,500 received from 11 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here